<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M785</article-id>
      <article-id pub-id-type="publisher-id">molbank-2012-M785</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>4,5,6,7-Tetrachloro-2-(1<italic>H</italic>-imidazol-2-yl)isoindoline-1,3-dione</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>W&#xF6;lfel</surname>
            <given-names>Sebastian</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Berndt</surname>
            <given-names>Frederik</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Friedrichs</surname>
            <given-names>Jessica</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Haese</surname>
            <given-names>Michael</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Joostberends</surname>
            <given-names>Janine</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Masri</surname>
            <given-names>Bader</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schnerre</surname>
            <given-names>Renate</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wabnik</surname>
            <given-names>Maximilian</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kunick</surname>
            <given-names>Conrad</given-names>
          </name>
          <xref rid="c1-molbank-2012-M785" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2012-M785">Institut f&#xFC;r Medizinische und Pharmazeutische Chemie, Technische Universit&#xE4;t Braunschweig, Beethovenstra&#xDF;e 55, D-38106 Braunschweig, Germany</aff>
      <author-notes>
        <corresp id="c1-molbank-2012-M785"><label>*</label> Author to whom correspondence should be addressed; E-Mail: <email>c.kunick@tu-braunschweig.de</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>09</day>
        <month>11</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2012</year>
      </pub-date>
      <volume>2012</volume>
      <issue>4</issue>
      <elocation-id>M785</elocation-id>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>08</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>11</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2012 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>4,5,6,7-Tetrachloro-2-(1<italic>H</italic>-imidazol-2-yl)isoindoline-1,3-dione was obtained by reaction of 2-aminoimidazole with 3,4,5,6-tetrachlorophthalic anhydride in refluxing acetic acid.</p>
      </abstract>
      <kwd-group>
        <kwd>tetrachlorophthalimide</kwd>
        <kwd>tetrachlorophthalic anhydride</kwd>
        <kwd>2-aminoimidazole</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>The biological activities of N-substituted tetrachlorophthalimides are broadly covered in the literature. Besides other properties, members of this compound class have been reported as biological response modifiers through regulation of tumor necrosis factor &#x3B1; [<xref ref-type="bibr" rid="B1-molbank-2012-M785">1</xref>], as &#x3B1;-glucosidase inhibitors [<xref ref-type="bibr" rid="B2-molbank-2012-M785">2</xref>], as liver X receptor antagonists [<xref ref-type="bibr" rid="B3-molbank-2012-M785">3</xref>], and as antihyperlipidemic agents [<xref ref-type="bibr" rid="B4-molbank-2012-M785">4</xref>]. In a recent paper members of the compound class were described as inhibitors of the protein kinase CK2 [<xref ref-type="bibr" rid="B5-molbank-2012-M785">5</xref>]. In the course of our studies on protein kinases and their ATP-competitive ligands [<xref ref-type="bibr" rid="B6-molbank-2012-M785">6</xref>,<xref ref-type="bibr" rid="B7-molbank-2012-M785">7</xref>,<xref ref-type="bibr" rid="B8-molbank-2012-M785">8</xref>,<xref ref-type="bibr" rid="B9-molbank-2012-M785">9</xref>] we were interested in structurally new N-substituted tetrachlorophthalimides as putative protein kinase inhibitors. A survey of the literature revealed that <italic>N</italic>-(imidazol-2-yl)tetrachlorophthalimides are hitherto unknown. The present paper reports a straightforward synthesis of the parent structure <bold>3</bold> in this compound class.</p>
      <p>For the synthesis of <bold>3</bold>, the free 2-aminoimidazole base (<bold>2</bold>), easily soluble in water and instable in the air [<xref ref-type="bibr" rid="B10-molbank-2012-M785">10</xref>], was released from the commercial sulfate with an aqueous solution of sodium carbonate [<xref ref-type="bibr" rid="B11-molbank-2012-M785">11</xref>]. After evaporation of the solvent, the remaining free 2-aminoimidazole (<bold>2</bold>) was refluxed with tetrachlorophthalic anhydride (<bold>1</bold>) in glacial acetic acid for five hours, applying a method reported by Pratt <italic>et al</italic>. (<xref ref-type="scheme" rid="molbank-2012-M785-sch001">Scheme 1</xref>) [<xref ref-type="bibr" rid="B12-molbank-2012-M785">12</xref>]. </p>
    <sec sec-type="methods">
      <title>Experimental</title>
      <sec>
        <title>General</title>
        <p>The melting point was determined in an open-glass capillary on an electric variable heater (Electrothermal IA 9100). The <sup>1</sup>H-NMR and the <sup>13</sup>C-NMR were recorded on a Bruker Avance AV II-600 spectrometer (NMR Laboratories of the Chemical Institutes of the Technische Universit&#xE4;t Braunschweig) using DMSO-<italic>d</italic>6 as solvent, chemical shifts are reported in relation to Me4Si (&#x3B4; = 0 ppm; bs = broad singlet). Tertiary C nuclei were identified by means of a <sup>13</sup>C-DEPT135 experiment. The infrared spectrum was recorded on a Thermo Nicolet FT-IR 200 spectrometer using KBr pellets. The UV spectrum was recorded on a Specord 40 spectrometer (Analytik Jena, Jena, Germany) using quartz cuvettes of 1 cm path length. For mass spectrometry a MAT95XL spectrometer (Thermofinnigan MAT, Bremen, Germany, Department of Mass Spectrometry of the Chemical Institutes of the Technische Universit&#xE4;t Braunschweig) was used. The elemental analysis was recorded on a CE Instruments FlashEA<sup>&#xAE;</sup>1112 Elemental Analyzer. The reaction was traced by TLC (Polygram SIL G/UV<sub>254</sub> 0.2 mm thickness by Macherey-Nagel). Ethanol 96% (technical grade containing 4% water) was used for extraction. Tetrachlorophthalic anhydride was purchased from Sigma Aldrich. 2-Aminoimidazole sulfate was purchased from Alfa Aesar. All starting materials were used as delivered without further purification.</p>
      </sec>
      <sec id="sec4-molbank-2012-M785">
        <title>4,5,6,7-Tetrachloro-2-(1H-imidazol-2-yl)isoindoline-1,3-dione <italic>(<bold>3</bold>)</italic></title>
        <p>Anhydrous sodium carbonate (477 mg, 4.50 mmol) was added to a solution of 2-aminoimidazole sulfate (594 mg, 2.25 mmol) in water (15 mL). The mixture was stirred for 30 minutes at room temperature. The solution was evaporated to dryness under reduced pressure. The residue was extracted six times with ethanol (96%, 5 mL portions, respectively). The combined ethanolic fractions were evaporated under reduced pressure to yield the free 2-aminoimidazole as brown oil. After addition of tetrachlorophthalic anhydride (858 mg, 3.00 mmol) and glacial acetic acid (10 mL) the mixture was refluxed open to the air for 5 h with stirring. A precipitate formed after cooling to room temperature, which was filtered off by suction to yield 0.500 g (63.5%) of a beige powder. Crystallization from a mixture of ethyl acetate and DMF (7:1) yielded an analytically pure sample as orange crystals.</p>
        <p>M.p.: 270&#x2013;273 &#xB0;C (dec.).</p>
        <p>MS (EI, rel. intensity) <italic>m/z</italic>: 212 (37), 214 (49), 216 (22), 240 (31), 242 (39), 244 (18), 314 (91), 316 (87), 318 (26), 349 [M<bold><sup>&#x25CF;</sup></bold><sup>+</sup>] (76), 351 (100), 353 (43).</p>
        <p>IR (KBr) (cm<sup>&#x2212;1</sup>): 735 (w), 748 (m), 1087 (w), 1127 (m), 1249 (w), 1304 (w), 1334 (w), 1368 (m), 1384 (m), 1475 (w), 1561 (w), 1578 (w), 1721 (s, C=O).</p>
        <p><sup>1</sup>H-NMR (600.1 MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x3B4; (ppm): 7.18 (s, 2H, CH), 12.44 (bs, 1H, NH).</p>
        <p><sup>13</sup>C-NMR (150.9 MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x3B4; (ppm): 128.3 (2C, C quat.), 129.3 (2C, C quat.), 129.3 (C tert.), 131.5 (C quat.), 139.5 (2C, C quat.), 139.5 (C tert.), 162.3 (2C, C quat.).</p>
        <p>UV/Vis (acetonitrile): <italic>&#x3BB;</italic><sub>max</sub> (<italic>&#x3B5;</italic>): 238 nm (51000)</p>
        <p>TLC (toluene:ethanol:formic acid 3:1:0.5 vol.): R<italic><sub>f</sub></italic> = 0.60</p>
        <p>Anal. calculated for C<sub>11</sub>H<sub>3</sub>Cl<sub>4</sub>N<sub>3</sub>O<sub>2</sub> (350.97): C, 37.64; H, 0.86; N, 11.97. Found: C, 37.64; H, 0.83; N, 11.96.</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="app1-molbank-2012-M785">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2012-M785-s001" xmlns:xlink=  "http://www.w3.org/1999/xlink" xlink:href="molbank-2012-M785-s001-mod.mol"><label>Supplementary File 1</label></supplementary-material>
        <supplementary-material id="molbank-2012-M785-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2012-M785-s001.mol"><label>Supplementary File 2</label></supplementary-material>
      </app>
    </app-group>
	<ack>
      <title>Acknowledgments</title>
      <p>The authors are grateful to H.-O. Burmeister, B. Babic, S. Meyer and P. Reich for recording the IR and UV spectra and performing the elemental analysis.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2012-M785">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyachi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Azuma</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ogasawara</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Uchimura</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Novel biological response modifiers: Phthalimides with tumor necrosis factor-&#x3B1; production-regulating activity</article-title>
          <source>J. Med. Chem.</source>
          <year>1997</year>
          <volume>40</volume>
          <fpage>2858</fpage>
          <lpage>2865</lpage>
          <pub-id pub-id-type="doi">10.1021/jm970109q</pub-id>
          <pub-id pub-id-type="pmid">9288167</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2012-M785">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sou</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mayumi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yamasaki</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kadoya</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sodeoka</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Novel &#x3B1;-glucosidase inhibitors with a tetrachlorophthalimide skeleton</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2000</year>
          <volume>10</volume>
          <fpage>1081</fpage>
          <lpage>1084</lpage>
          <pub-id pub-id-type="doi">10.1016/S0960-894X(00)00161-X</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2012-M785">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Motoshima</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Noguchi-Yachide</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Sugita</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Ishikawa</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Separation of &#x3B1;-glucosidase-inhibitory and liver X receptor-antagonistic activities of phenethylphenyl phthalimide analogs and generation of LXR&#x3B1;-selective antagonists</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2009</year>
          <volume>17</volume>
          <fpage>5001</fpage>
          <lpage>5014</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmc.2009.05.066</pub-id>
          <pub-id pub-id-type="pmid">19539483</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2012-M785">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abdel-Aziz</surname>
              <given-names>A.A.-M.</given-names>
            </name>
            <name>
              <surname>El-Azab</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Attia</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Al-Obaid</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Al-Omar</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>El-Subbagh</surname>
              <given-names>H.I.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and biological evaluation of some novel cyclic-imides as hypoglycaemic, anti-hyperlipidemic agents</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2011</year>
          <volume>46</volume>
          <fpage>4324</fpage>
          <lpage>4329</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2011.07.002</pub-id>
          <pub-id pub-id-type="pmid">21783284</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2012-M785">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Golub</surname>
              <given-names>A.G.</given-names>
            </name>
            <name>
              <surname>Yakovenko</surname>
              <given-names>O.Y.</given-names>
            </name>
            <name>
              <surname>Prykhod'ko</surname>
              <given-names>A.O.</given-names>
            </name>
            <name>
              <surname>Lukashov</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Bdzhola</surname>
              <given-names>V.G.</given-names>
            </name>
            <name>
              <surname>Yarmoluk</surname>
              <given-names>S.M.</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of 4,5,6,7-tetrahalogeno-1<italic>H</italic>-isoindole-1,3(2<italic>H</italic>)-diones as inhibitors of human protein kinase CK2</article-title>
          <source>Biochem. Biophys. Acta Protein Proteonomics</source>
          <year>2008</year>
          <volume>1784</volume>
          <fpage>143</fpage>
          <lpage>149</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbapap.2007.10.009</pub-id>
          <pub-id pub-id-type="pmid">18021749</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2012-M785">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Egert-Schmidt</surname>
              <given-names>A.-M.</given-names>
            </name>
            <name>
              <surname>Dreher</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Dunkel</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Kohfeld</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Preu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ehlert</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Mutschler</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Totzke</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Sch&#xE4;chtele</surname>
              <given-names>C.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of 2-anilino-9-methoxy-5,7-dihydro-6<italic>H</italic>-pyrimido[5,4-<italic>d</italic>][1]benzazepin-6-ones as dual PLK1/VEGF-R2 kinase inhibitor chemotypes by structure-based lead generation</article-title>
          <source>J. Med. Chem.</source>
          <year>2010</year>
          <volume>53</volume>
          <fpage>2433</fpage>
          <lpage>2442</lpage>
          <pub-id pub-id-type="doi">10.1021/jm901388c</pub-id>
          <pub-id pub-id-type="pmid">20170163</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2012-M785">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McGrath</surname>
              <given-names>C.F.</given-names>
            </name>
            <name>
              <surname>Pattabiraman</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kellogg</surname>
              <given-names>G.E.</given-names>
            </name>
            <name>
              <surname>Lemcke</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kunick</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Sausville</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Zaharevitz</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Gussio</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Homology model of the CDK1/cyclin B complex</article-title>
          <source>J. Biomol. Struct. Dyn.</source>
          <year>2005</year>
          <volume>22</volume>
          <fpage>493</fpage>
          <lpage>502</lpage>
          <pub-id pub-id-type="doi">10.1080/07391102.2005.10531227</pub-id>
          <pub-id pub-id-type="pmid">15702922</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2012-M785">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tolle</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Dunkel</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Oehninger</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Ott</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Preu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Haase</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Behrends</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>P.G.</given-names>
            </name>
            <name>
              <surname>Totzke</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Sch&#xE4;chtele</surname>
              <given-names>C.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Synthesis and structure of fluorescent chelate boron complexes of 4-anilinomethylidene-1-benzazepine-2,5-dione ligands</article-title>
          <source>Synthesis</source>
          <year>2011</year>
          <fpage>2848</fpage>
          <lpage>2858</lpage>
        </citation>
      </ref>
      <ref id="B9-molbank-2012-M785">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xie</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Lemcke</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Gussio</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Zaharevitz</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Leost</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Meijer</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kunick</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Epoxide-containing side chains enhance antiproliferative activity of paullones</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2005</year>
          <volume>40</volume>
          <fpage>655</fpage>
          <lpage>661</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2005.02.004</pub-id>
          <pub-id pub-id-type="pmid">15935900</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2012-M785">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weinmann</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Harre</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Koenig</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Merten</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Tilstam</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Efficient and environmentally friendly synthesis of 2-amino-imidazole</article-title>
          <source>Tetrahedron Lett.</source>
          <year>2002</year>
          <volume>43</volume>
          <fpage>593</fpage>
          <lpage>595</lpage>
          <pub-id pub-id-type="doi">10.1016/S0040-4039(01)02226-2</pub-id>
        </citation>
      </ref>
      <ref id="B11-molbank-2012-M785">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Voegel</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Altorfer</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Benner</surname>
              <given-names>S.A.</given-names>
            </name>
          </person-group>
          <article-title>The donor-acceptor-acceptor purine analog: Transformation of 5-aza-7-deaza-1<italic>H</italic>-isoguanine (=4-aminoimidazo[1,2-<italic>a</italic>]-1,3,5-triazin-2(1<italic>H</italic>)-one) to 2'-deoxy-5-aza-7-deaza-isoguanosine using purine nucleoside phosphorylase</article-title>
          <source>Helv. Chim. Acta</source>
          <year>1993</year>
          <volume>76</volume>
          <fpage>2061</fpage>
          <lpage>2069</lpage>
          <pub-id pub-id-type="doi">10.1002/hlca.19930760520</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2012-M785">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pratt</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>C.O.</given-names>
            </name>
          </person-group>
          <article-title>Phthalic acid derivatives: Constitution and color. XIV. Some derivatives of tetrabromophthalimide</article-title>
          <source>J. Am. Chem. Soc.</source>
          <year>1918</year>
          <volume>40</volume>
          <fpage>1415</fpage>
          <lpage>1425</lpage>
          <pub-id pub-id-type="doi">10.1021/ja02242a008</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Scheme</title>
      <fig id="molbank-2012-M785-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2012-M785-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthesis of the title compound <bold>3</bold>.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2012-M785-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
